ARF and ARF Mimics to Inhibit Myc Protein Function

Summary

The c-Myc oncogene is bound by p19Arf, which inhibits c-Myc's ability to transform cells while augmenting apoptosis. This provides the basis for screening assays that examine the ability of various candidate substances to promote p19Arf interactions, or to substitute therefor.

Patent

U.S. Patent # 7,625,716: Methods for assessing p19-Arf interactions in cMyc

Inventors: 
Stephen Hann
Licensing manager: 
Mike Villalobos

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter